GLOBAL EPIDERMAL GROWTH FACTOR (EGF) (CAS 62253-63-8) MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Apr 2019 124

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival.

EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that’s why most skin care maker use EGF to care our skin.

And we only investigate the epidermal growth factor (EGF) cosmetic, take no account of the epidermal growth factor (EGF) for research use.

Scope of the Report:
The classification of Epidermal Growth Factor (EGF) includes liquid and powder. The proportion of liquid in 2016 is about 25%, the proportion of powder in 2016 is about 75%.

The application of Epidermal Growth Factor (EGF) is divided into EGF Cream, EGF Lotion, EGF Mask and others. The most of Epidermal Growth Factor (EGF) is EGF Cream, and the market share of that is about 45% in 2016.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 34% in 2016. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 25% in 2016. And South America in the third largest consumption region with the consumption market share of 10%.

Market competition is intense. Pavay, Radiant, BIO-FD&C, LipoTrue, BIOEFFECT are the leaders of the industry, with high-end customers in the industry.

The worldwide market for Epidermal Growth Factor (EGF) (CAS 62253-63-8) is expected to grow at a CAGR of roughly 5.8% over the next five years, will reach 140 million US$ in 2024, from 110 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Epidermal Growth Factor (EGF) (CAS 62253-63-8) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Pavay
- Radiant
- BIO-FD&C
- LipoTrue
- BIOEFFECT

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Liquid
- Powder

Market Segment by Applications, can be divided into
- EGF Cream
- EGF Lotion
- EGF Mask
- Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Epidermal Growth Factor (EGF) (CAS 62253-63-8) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Epidermal Growth Factor (EGF) (CAS 62253-63-8), with price, sales, revenue and global market share of Epidermal Growth Factor (EGF) (CAS 62253-63-8) in 2017 and 2018.
Chapter 3, the Epidermal Growth Factor (EGF) (CAS 62253-63-8) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Epidermal Growth Factor (EGF) (CAS 62253-63-8) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Epidermal Growth Factor (EGF) (CAS 62253-63-8) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Epidermal Growth Factor (EGF) (CAS 62253-63-8) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Related reports :

(May 19)

Scope of the Report: The worldwide market for Microbial Products is expected to grow at a CAGR of roughly over the next five years, w...

(May 19)

Scope of the Report: The global Protein Labeling market is valued at million USD in 2018 and is expected to reach million USD by the ...

(May 19)

Scope of the Report: The worldwide market for Microbial Growth Media is expected to grow at a CAGR of roughly over the next five year...

(May 19)

Scope of the Report: The worldwide market for Protein Kinase Inhibitor is expected to grow at a CAGR of roughly over the next...

(May 19)

Scope of the Report: The worldwide market for Cancer Biomarkers is expected to grow at a CAGR of roughly over the next five years, wi...

(Apr 19)

Scope of the Report: The worldwide market for Cardiac Biomarker is expected to grow at a CAGR of roughly over the next five years, wi...

GLOBAL EPIDERMAL GROWTH FACTOR (EGF) (CAS 62253-63-8) MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Biotechnology market as per your needs. Get the best of Biotechnology research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

Avail 15% Discount, Use MAY15 Coupon Code

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy